ITC Investigates India Trade Practices

02.17.14 | By

At the International Trade Commission (ITC) hearing on the investigation into India's trade policies, Rod Hunter, PhRMA’s Senior Vice President for International Affairs, highlighted the industry's concerns and hopes surrounding India’s policies.

ITC Testimony

NORD on the Need for More Collaboration to Drive Progress for Rare Disease Patients

02.17.14 | By

Many biopharmaceutical companies are actively engaged in the research and development of therapies to treat rare disease, despite challenges such as much smaller patient populations than more common diseases. Companies seek opportunities to partner with patient advocacy organizations, academia and the government in order to make even greater progress against rare disease, which collectively affect 1 in 10 Americans.

Patient-Centered Pathways for Advancing Cancer Care

02.14.14 | By

There's been a lot of discussion lately about the need to control rising health care costs, and the role of new medicines and medical technology. Nowhere has this discussion been sharper than in the area of oncology. At PhRMA, we’ve been joining in many of these discussions, working with other stakeholders to identify solutions to sustain continued progress and support efficient delivery of optimal patient care.

Importance of Keeping Patients Informed

02.14.14 | By

Within the medical community there is so much truth to the saying, “knowledge is power.” Whether it’s sharing information about a new medicine in development that could save a patient’s life, or sharing resources and ideas to change a patient’s life, it is essential that patients, doctors, and other members of the health care ecosystem stay well informed and disseminate their knowledge.

It’s Valentine’s Day, Have a Heart

02.14.14 | By

It’s no coincidence that February is American Heart Month and host to Valentine’s Day, and as a result, there is no better time to focus on your heart.

Fighting Prescription Drug Abuse

02.11.14 | By

With the tragic news of Philip Seymour Hoffman’s death, the national conversation around addiction has gained a new focal point. Though Hoffman died from a heroin overdose, his death has intensified an ongoing discussion about the abuse and misuse of painkillers and other medicines. 

Nearly 200 New Medicines in Development for Diabetes

Washington, D.C. (February 11, 2014) — America’s biopharmaceutical research companies currently are developing 180 innovative new medicines to help the nearly 400 million people who have diabetes worldwide.

Why Intellectual Property Matters for Patients

02.11.14 | By

The importance of protecting intellectual property cannot be overstated. For the biopharmaceutical industry, ensuring our ability to innovate is essential for continued R&D to help patients live longer, healthier lives.

The Ongoing Battle for Patient Health

02.07.14 | By

Every day there is a war to wage against the world’s most devastating diseases. It is a fight we must win to make the world a safer, healthier place for our patients, and this week we discussed some of the battles currently underway.

Pages

Subscribe to RSS - Opinion